Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
7 October 2008NVA237 Phase II results presented at ERS Meeting show efficacy and tolerability with potentially faster onset than tiotropium
9 September 2008Vectura Group plc confirms Sandoz as partner on VR315 and VR632
30 July 2008Vectura Group Plc: Interim Management Statement for the period to 30 July 2008
Latest press releases
Next events
31 Oct 2008Annual General Meeting - 10.00 a.m. at Olswangs Offices, London
2-3 Dec 2008
Piper Jaffray 20th Annual Health Care Conference, New York
Investor Calendar
